Amanta Healthcare Limited submitted a regulatory filing to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure covers the quarter ended December 31, 2025.

The company confirms that there has been no deviation or variation in the use of proceeds from funds raised through its Initial Public Offering (IPO). The statement was reviewed by the Audit Committee of the company, which had no comments. The auditors also had no comments.

Key Financial Details

  • Total Amount Raised through IPO: ₹126 crore
  • Monitoring Agency: CRISIL Ratings Limited
  • Reporting Quarter: Ended December 31, 2025

Fund Utilization Breakdown (in ₹ lakhs):

1. SteriPort Manufacturing Line at Hariyala, Kheda, Gujarat

  • Original Allocation: ₹7,000.00 lakhs
  • Funds Utilized: ₹3,080.86 lakhs
  • Purpose: Capital expenditure for civil construction work and purchase of equipment, plant and machinery
  • Deviation/Variation: None

2. SVP Manufacturing Line at Hariyala, Kheda, Gujarat

  • Original Allocation: ₹3,013.11 lakhs
  • Funds Utilized: ₹0.00 lakhs
  • Purpose: Capital expenditure for civil construction work, purchase of equipment, plant and machinery
  • Deviation/Variation: None

3. General Corporate Purposes

  • Original Allocation: ₹660.46 lakhs
  • Modified Allocation: ₹302.08 lakhs (revised downward)
  • Funds Utilized: ₹302.08 lakhs
  • Deviation/Variation: None

4. Issue Expenses

  • Original Estimated Expenses: ₹1,926.43 lakhs
  • Actual Expenses: ₹2,284.81 lakhs
  • Variance: Higher by ₹358.38 lakhs than estimated

Important Adjustment Disclosure

During the quarter ended September 30, 2025, the net proceeds from the IPO were revised from ₹10,673.57 lakhs to ₹10,315.19 lakhs. This revision was due to actual issue expenses being higher than estimated in the Prospectus by ₹358.38 lakhs. The excess amount was adjusted against the General Corporate Purposes allocation.

The document was digitally signed by Dinodia Nikhita, Company Secretary & Compliance Officer, and Paras Mehta, Chief Financial Officer, on May 29, 2026.